Previous Close | 13.66 |
1-Year Change | 0.81% |
6-Months Change | 23.84% |
3-Months Change | 23.73% |
Moving Avg (50d) | 11.212 |
Moving Avg (200d) | 11.603 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 1.76B |
Beta (3-Years) | 1.18 |
Revenue Growth (ttm) | -50.74% |
Net Profit Margin (ttm) | 16.92% |
Return On Assets (ttm) | 6.28% |
EPS (ttm) | 0.4 |
PE Ratio (ttm) | 34.15 |
Dividend Yield | % |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Biotechnology |
Country: | United States |